Quest Diagnostics Surges to 241st in Daily Rankings with $476 Million Turnover

On July 22, 2025, Quest Diagnostics (DGX) saw a significant increase in trading volume, with a turnover of $476 million, marking a 42.83% rise from the previous day. This surge placed Quest Diagnostics at the 241st position in the daily stock market rankings. The company's stock price also rose by 7.08%.

Quest Diagnostics has revised its financial outlook for the fiscal year 2025, projecting net revenue to range between $10.80 billion and $10.92 billion. This adjustment reflects a positive shift from the previous guidance of $10.70 billion to $10.85 billion, indicating the company's confidence in its revenue growth prospects.

In the second quarter of 2025, Quest Diagnostics reported a 15.7% increase in revenue for its Diagnostic Information Services, reaching $2.70 billion. This growth was accompanied by a substantial 51.5% surge in cash provided by operations, amounting to $544 million. The company's strong financial performance in Q2 2025 was further highlighted by its better-than-expected revenue, which saw a 15.2% year-on-year increase to $2.76 billion.

Quest Diagnostics has also updated its full-year 2025 outlook, with revenues now expected to fall within the range of $10.80 billion to $10.92 billion. This revision underscores the company's robust demand for its diagnostic tests and services, driving its revenue and earnings growth.